In the world economic growth, the Radiopharmaceuticals industry has also suffered a certain impact, but still maintained a relatively optimistic growth, the past four years, Radiopharmaceuticals market size to maintain the average annual growth rate of XXX from XXX million $ in 2014 to XXX million $ in 2019, SMI analysts believe that in the next few years, Radiopharmaceuticals market size will be further expanded, we expect that by 2024, The market size of the Radiopharmaceuticals will reach XXX million $.
Overview
With the increase in demand for diagnostic imaging services, more technologists are turning towards Radiopharmaceuticals, a booming industry that promises bright financial prospects. The cost of imaging processes has gone up, and with the increasing number of diseases that can be detected through imaging technologies, the demand for technologists and technicians who possess the skills and knowledge required by radiologists to do so is also increasing. With proper training, radiology tech training is something that any student interested in the field should be sure to take into account. The global radiopharmaceuticals market focuses on six regions namely North America, Latin America, Europe, Asia Pacific, Middle East, and Africa. The global radiopharmaceuticals market is expected to witness significant growth during the forecast period, owing to rising initiatives to reduce the supply-demand gap of Mo-99.
Market Drivers
Increasing prevalence of target conditions such as tuberculosis, measles, tetanus, and hepatitis B is expected to drive growth of the global radiopharmaceuticals market during the forecast period. According to the World Health Organization (WHO), in 2019, around 1.4 million died from tuberculosis (TB) and around 10 million people were diagnosed with the same. This, in turn, has increased the demand for radiopharmaceuticals worldwide for effective treatment. Hence, such factors are expected to drive growth of the global radiopharmaceuticals market during the forecast period. Furthermore, rising initiatives to reduce the supply-demand gap of Mo-99 are expected to propel the global radiopharmaceuticals market growth over the forecast period.
Market Restraint
Short half-life of radiopharmaceuticals is expected to restrain growth of the global radiopharmaceuticals during the forecast period.
Regional Insights
Among regions, North America is expected to witness significant growth in the global radiopharmaceuticals market during the forecast period. This is owing to growing adoption of nuclear medicine in cancer treatment across the region. Moreover, Asia Pacific is expected to register a robust growth rate, owing to improving healthcare infrastructure in the region.
Competitive Section
Major companies involved in the global radiopharmaceuticals market are Bracco Imaging, Bayer, Mallinckrodt, Nordion, Triad Isotopes, Lantheus, IBA Group, GE Healthcare, China Isotope & Radiation, Jubilant Pharma, and Eli Lilly.
For instance, in March 2021, BWXT Medical Ltd. entered into a joint venture with Global Medical Solutions, Ltd. to manufacture and distribute radioisotopes and radiopharmaceuticals in Asia Pacific.
This Report covers the manufacturers' data, including: shipment, price, revenue, gross profit, interview record, business distribution etc., these data help the consumer know about the competitors better. This report also covers all the regions and countries of the world, which shows a regional development status, including market size, volume and value, as well as price data.
Besides, the report also covers segment data, including: type segment, industry segment, channel segment etc. cover different segment market size, both volume and value. Also cover different industries clients information, which is very important for the manufacturers. If you need more information, please contact SMI
Section 1: Definition
Section (2 3): Manufacturer Detail
Bracco Imaging
Bayer
Mallinckrodt
Nordion
Triad Isotopes
Lantheus
IBA Group
GE Healthcare
China Isotope & Radiation
Jubilant Pharma
Eli Lilly
Advanced Accelerator Applications
SIEMENS
Dongcheng
Navidea
Section 4: Region Segmentation
North America Country (United States, Canada)
South America
Asia Country (China, Japan, India, Korea)
Europe Country (Germany, UK, France, Italy)
Other Country (Middle East, Africa, GCC)
Section (5 6 7):
Product Type Segmentation
Diagnostic Radioisotopes
Therapeutic Radioisotopes
Industry Segmentation
Oncology
Cardiology
Channel (Direct Sales, Distributor) Segmentation
Section 8: Trend (2019-2024)
Section 9: Product Type Detail
Section 10: Downstream Consumer
Section 11: Cost Structure
Section 12: Conclusion
Request Discount 
Inquire Before Buy
